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During recent years, the significant influence of mitochondria on osteoarthritis (OA), the
most common joint disease, has been consistently demonstrated. Not only mitochondrial
dysfunction but also mitochondrial genetic polymorphisms, specifically the mitochondrial
DNA haplogroups, have been shown to have an important influence on different OA-
related features, including the prevalence, severity, incidence, and progression of the
disease. This influence could probably be mediated by the role of mitochondria in the
regulation of different processes involved in the pathogenesis of OA, such as energy
production, the generation of reactive oxygen and nitrogen species, apoptosis, and
inflammation. The regulation of these processes is at least partially controlled by the bi-
directional communication between the nucleus and mitochondria, which permits the
regulation of adaptation to a wide range of stressors and the maintenance of cellular
homeostasis. This bi-directional communication consists of an “anterograde regulation”
by which the nucleus regulates mitochondrial biogenesis and activity and a “retrograde
regulation” by which both mitochondria and mitochondrial genetic variation exert a
regulatory signaling control over the nuclear epigenome, which leads to the modulation
of nuclear genes. Throughout this mini review, we will describe the evidence that
demonstrates the profound influence of the mitochondrial genetic background in the
pathogenesis of OA, as well as its influence on the nuclear DNA methylome of the only cell
type present in the articular cartilage, the chondrocyte. This evidence leads to serious
consideration of the mitochondrion as an important therapeutic target in OA.
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Osteoarthritis (OA) is the most common chronic progressive disorder that involves movable joints,
occurring in 10-20% of the population over 50 years of age; the incidence of OA is estimated to
double within the next 30 years (Blanco et al., 2011). The pathogenesis of OA is characterized by
extracellular matrix degradation and cell stress initiated by micro- and macro-injuries that lead to
the activation of maladaptive repair responses, including proinflammatory pathways of innate
immunity. The disease manifests first as a molecular derangement (abnormal tissue metabolism)
followed by anatomical and/or physiological derangements (characterized by cartilage degradation,
bone remodeling, osteophyte formation, joint inflammation, and the loss of normal joint function)January 2020 | Volume 10 | Article 13351
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considered a disease of the whole joint as an organ, resulting in
organ dysfunction or joint failure (Blanco, 2014). In addition,
this disease is one of the most common reasons for visits to
primary care physicians and is also the leading cause of
permanent work incapacitation. OA has no effective treatment
today, and joint replacement is the only choice in cases of total
joint dysfunction.
The nature of OA is heterogeneous, because a combination of
factors such as occupation, age, gender, body mass index, and
genetics have a profound influence on its pathogenesis. As a
consequence of this, several different phenotypes characterize
this disease, including inflammatory, aging-related, metabolic,
pain, and post-traumatic phenotypes (Berenbaum, 2013; Sellam
and Berenbaum, 2013; Blanco et al., 2018). In agreement with
this heterogeneous nature, it has also been proposed that, on the
one hand, mitochondria and mitochondrial DNA (mtDNA)
have an important impact on the development of OA (Valdes
and Goldring, 2017; Blanco et al., 2018; Li et al., 2019) and, on
the other hand, that epigenetics is one of the main actors
involved in the phenotypic modulation that articular
chondrocytes, the only cell type present in articular cartilage,
undergo during the OA process (Roach et al., 2005; Reynard and
Loughlin, 2012; Blanco and Rego-Pérez, 2014). In this sense, it
has also been consistently shown that specific mtDNA
polymorphisms, called mtDNA haplogroups, have been
associated not only with different OA-related features such as
the incidence or progression of the disease (Fernandez-Moreno
et al., 2017a; Fernandez-Moreno et al., 2017b; Koo et al., 2019)
but also with the differential methylation status of articular
cartilage (Cortes-Pereira et al., 2019). In light of the
involvement of mitochondrial DNA in cell behavior and
metabolism (Wallace et al., 1999; Martínez-Redondo et al.,
2010), in this review, we discuss some of the evidence
implicating the epigenetic effect of mtDNA variation in the
pathogenesis of OA.MITOCHONDRIA IN OSTEOARTHRITIS
Because articular chondrocytes are highly glycolytic cells that
obtain their energy mainly from anaerobic glucose metabolism,
the role of mitochondria in the pathogenesis of OA was not
studied in depth until early 2000. However, a large number of
studies have demonstrated the profound influence of
mitochondria in the pathogenesis of OA.
Terkeltaub and co-workers published a full review describing
how mitochondrial impairment of chondrocytes is an important
mediator of the establishment of OA (Terkeltaub et al., 2002).
Specifically, these and other authors described that
mitochondrial dysfunction mediates several specific pathogenic
pathways implicated in the OA process, including oxidative
stress, chondrocyte apoptosis, cartilage matrix calcification,
autophagy, impaired anabolic and growth response of
chondrocytes, and increased cytokine-induced inflammation
(Terkeltaub et al., 2002; Blanco et al., 2004; Lotz and Loeser,Frontiers in Genetics | www.frontiersin.org 22012; López de Figueroa et al., 2015). In agreement with these
findings, our group also demonstrated that, compared with
healthy chondrocytes from patients of the same age,
osteoarthritic chondrocytes have reduced mitochondrial
activity, mainly in complexes II and III, and increased
mitochondrial mass (Maneiro et al., 2003). In addition, the
apoptotic mitochondrial pathway is implicated in the apoptosis
of osteoarthritic chondrocytes (Hwang and Kim, 2015), and the
inhibition of mitochondrial complexes III and V increases the
mitochondrial-mediated inflammatory response in OA
chondrocytes mediated by an overproduction of reactive
oxygen species (ROS) (Vaamonde-García et al., 2012).
Mitochondrial dysfunction has also been associated with a
significant downregulation of superoxide dismutase 2 (SOD2)
(Gavriilidis et al., 2013), one of the major mitochondrial
antioxidant proteins, whose levels are also diminished in the
superficial layers of end-stage OA cartilage (Ruiz-Romero et al.,
2009; Scott et al., 2010).
Mitophagy is a form of autophagy, a process that involves the
removal of damaged macromolecules and organelles to regulate
cell homeostasis (Choi et al., 2013); specifically, mitophagy
consists of the elimination of depolarized and damaged
mitochondria. Different studies have demonstrated that the
activation of this process protects against mitochondrial
dysfunction, prevents ROS production and improves
chondrocyte survival under pathological conditions (López de
Figueroa et al., 2015; Ansari et al., 2018). It has also been
demonstrated that mitochondrial biogenesis is deficient in
human OA chondrocytes, leading the chondrocyte to adopt
procatabolic responses; however, the activation of the AMP-
activated protein kinase (AMPK)-NAD-dependent protein
deacetylase sirtuin-1 (SIRT1)-peroxisome proliferator-activated
receptor g co-activator 1a (PGC1a) pathway reverses impaired
mitochondrial biogenesis, which is mediated by mitochondrial
transcriptional factor A (TFAM) (Wang et al., 2015).mtDNA HAPLOGROUPS
AND OSTEOARTHRITIS
Mitochondria are considered unique organelles because they
contain their own maternally inherited DNA, the mtDNA,
containing 2 rRNAs, 22 tRNAs, and 13 essential mitochondrial
protein-coding genes. The mutation rate of this circular molecule
is higher than that of the nuclear DNA, mainly due to i) its
proximity to the main source of ROS production, ii) the lack of
an efficient repair system, and iii) the higher replication rate of
mtDNA (Li et al., 2019). As a consequence of this, mtDNA
sequences evolved by sequentially accumulating functional
mutations along radiating maternal lineages when humans
migrated out of Africa and adapted their energy metabolism to
different environments, giving rise to mtDNA haplogroups
(Torroni et al., 1996; Wallace, 2016). However, these types of
mtDNA variants, though providing an important degree of
adaptation as people migrated into new environments, might
also have contributed to modern human disorders such asJanuary 2020 | Volume 10 | Article 1335
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(Ruiz-Pesini et al., 2004; Marom et al., 2017).
In this sense, OA is not an exception. During recent years,
different studies have shown clinical associations between
specific mtDNA haplogroups and different OA-related features,
including the prevalence, progression, and incidence of the
disease (Table 1).
mtDNA Haplogroups and the Prevalence
of OA
Different studies have shown significant associations between
specific mtDNA haplogroups and the prevalence of OA.
Specifically, mtDNA variants belonging to the European
cluster JT have been associated with a lower risk of knee and
hip OA in a cohort of Spanish patients (Rego-Perez et al., 2008;
Rego et al., 2010). mtDNA haplogroup T was also associated with
a decreased risk of knee OA in a population from the United
Kingdom (Soto-Hermida et al., 2014a); however, a later study in
a larger population cohort from the same country failed to
replicate these findings (Hudson et al., 2013). In addition,
Asian mtDNA haplogroups B and G have been described as
protective and risk factors respectively for knee OA in a
population of southern China (Fang et al., 2014). The authors
have proposed that the mechanisms that could explain that
association are related to the alteration of both mitochondrial
function and OA-related signaling pathways (Fang et al., 2016).Frontiers in Genetics | www.frontiersin.org 3A meta-analysis summarizing most of the studies described
above concluded that mtDNA cluster JT is associated with a
lower risk of OA prevalence in Spanish populations (Shen
et al., 2014).
A plausible cause for the lack of replication among different
case-control studies, even when nuclear DNA polymorphisms
are analyzed, could be the unavailability of knee (or hip)
radiographs for most population-based controls. This is not a
minor issue, since up to 50% of people without joint symptoms
may develop radiographic changes comparable to OA (Hannan
et al., 2000). In this sense, our group has always considered the
radiological status, because we believe that both mitochondrial
dysfunction and mtDNA variation have a greater impact on the
evolution of joint structure than on pain.
mtDNA Haplogroups and Radiographic OA
Progression and Incidence
The use of well-characterized prospective cohorts of patients
permits rigorous studies to analyze the influence of mtDNA
haplogroups on the rate of progression and incidence of OA over
time. mtDNA variants within mitochondrial cluster JT were
associated with lower rates of radiographic knee OA progression
in different world populations, including Spain, the USA, and the
Netherlands. Specifically, in a Spanish cohort, mtDNA cluster JT
was associated with a lower rate of radiographic progression in
terms of Kellgren and Lawrence grade (Kellgren and Lawrence,TABLE 1 | Published associations of mtDNA variants with specific OA-related features.
Study cohort Population Haplogroup OR (95%CI) p-value/effect on the biomarker Reference
OA prevalence
Spanish 457 OA cases, 262 controls J OR = 0.460 (0.282-0.748) p = 0.002 (Rego-Perez et al., 2008)
JT OR = 0.564 (0.384-0.828) p = 0.005
Spanish 550 OA cases, 505 controls J OR = 0.519 (0.271-0.994) p = 0.048 (Rego et al., 2010)
UK 453 OA cases, 280 controls T OR = 0.574 (0.350-0.939) p = 0.027 (Soto-Hermida et al., 2014a)
UK 7846 OA cases, 5402 controls J OR = 1.190 (0.720-1.950) ns & (Hudson et al., 2013)
Meta-analysis 2557 OA cases, 1339 controls J OR = 0.570 (0.460-0.710) p < 0.0001 (Shen et al., 2014)
2478 OA cases, 1173 controls JT OR = 0.700 (0.580-0.840) p = 0.0002
Chinese 187 OA cases, 420 controls G OR = 3.834 (1.139-12.908) p = 0.003 (Fang et al., 2014)
B OR = 0.503 (0.283-0.893) p = 0.019
OA progression
OAI 891 knee OA cases T HR = 0.499 (0.261-0.819) p < 0.05 (Soto-Hermida et al., 2014b)
Spanish 281 knee OA cases JT* HR = 0.584 (0.354-0.964) p = 0.036 (Soto-Hermida et al., 2015)
CHECK 431 knee OA cases T HR = 0.645 (0.419-0.978) p < 0.05 (Fernandez-Moreno et al., 2017b)
JT HR = 0.707 (0.501-0.965) p < 0.05
Meta-analysis 1603 knee OA cases T HR = 0.612 (0.454-0.824) p = 0.001 (Fernandez-Moreno et al., 2017b)
JT HR = 0.765 (0.624-0.938) p = 0.009
OA incidence
OAI 2579 subjects J HR = 0.680 (0.470-0.968) p < 0.05 (Fernandez-Moreno et al., 2017a)
CHECK 635 subjects J HR = 0.728 (0.469-0.998) p < 0.05 (Fernandez-Moreno et al., 2017a)
Meta-analysis 3214 subjects J HR = 0.702 (0.541-0.912) p = 0.008 (Fernandez-Moreno et al., 2017a)
Korean 438 subjects B RR = 2.389 (1.315-4.342) p = 0.004 (Koo et al., 2019)
OA biomarkers
Spanish 73 knee OA cases, 77 controls J Decreased serum levels of catabolic type II collagen biomarkers& (Rego-Perez et al., 2010)
H Increased serum levels of catabolic type II collagen biomarkers&
Spanish 73 knee OA cases, 77 controls J Decreased serum levels of MMP-13& (Rego-Perez et al., 2011)
H Increased serum levels of MMP-13 and MMP-3&
Spanish 79 knee OA cases, 166 controls J Lower NO production (Fernandez-Moreno et al., 2011)
OAI 255 knee OA cases J Fewer large tibiofemoral BMLs (Rego-Perez et al., 2018)JanuarymtDNA, mitochondrial DNA; UK, United Kingdom; OA, Osteoarthritis; OAI, Osteoarthritis Initiative; CHECK, Cohort Hip and Cohort Knee; NO, nitric oxide; BMLs, bone marrow lesions;
MMP, metalloproteinase; OR, odds ratio; HR, hazard ratio; RR, risk ratio; ns, non-significant; (*) when compared with mtDNA cluster KU; (&) p-value after multiple testing correction.2020 | Volume 10 | Article 1335
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requiring total joint replacement (Soto-Hermida et al., 2015).
mtDNA haplogroup T was associated with a decreased rate of
radiographic knee OA progression, as well as a reduced loss of
knee cartilage integrity over time in patients of the Osteoarthritis
Initiative (OAI) of the US National Institutes of Health (NIH)
(Soto-Hermida et al., 2014b). This association was then
replicated in the CHECK cohort (cohort hip and cohort knee),
another prospective cohort of OA patients from the Netherlands
(Fernandez-Moreno et al., 2017b). Finally, a subsequent meta-
analysis including the above-mentioned studies confirmed that
mtDNA variants of the JT cluster act as protective factors against
the radiographic progression of the disease (Fernandez-Moreno
et al., 2017b).
In terms of disease incidence, a meta-analysis including 3217
individuals from the OAI and CHECK cohorts concluded that,
compared with the most common Caucasian haplogroup H,
subjects with mtDNA haplogroup J show a lower rate of incident
knee OA over an eight-year period (Fernandez-Moreno et al.,
2017a). This study included the design of a cellular model of
transmitochondrial cybrids, consisting of cells with a defined and
uniform nuclear background containing mitochondria from
different sources, to demonstrate the existence of functional
differences between haplogroups H and J; the study concluded
that, compared with H cybrids, J cybrids produce less ATP, but
this was accompanied with lower amounts of peroxynitrite and
mitochondrial superoxide anion together with a lower rate of
apoptosis under stress conditions as well as an increased ability
to cope with oxidative stress (Fernandez-Moreno et al., 2017a).
Another study in Korean populations showed that Asian
mtDNA haplogroup B, described as a protective factor against
knee OA prevalence in a population from the south of China
(Fang et al., 2014), was a risk factor for the incidence of knee OA
over an eight-year period (Koo et al., 2019).
mtDNA Haplogroups and Biomarkers in OA
In an effort to detect structural changes in an early stage of the
disease, to monitor disease progression, or even to assess
therapeutic responses with more sensitivity and reliability,
molecular biomarkers have been developed in OA (Garnero et
al., 2002; Rousseau and Delmas, 2007; Camacho-Encina et al.,
2019). In a set of clinically relevant studies, OA-protective
haplogroup J has been significantly associated with lower
serum levels of catabolic type II collagen biomarkers and
matrix metalloproteinases, in contrast to haplogroup H
carriers, which showed significantly higher levels (Rego-Perez
et al., 2010; Rego-Perez et al., 2011). Despite not being
considered a biomarker of the disease, although higher-than-
normal production has been described in OA chondrocytes
(Maneiro et al., 2005; Henrotin and Kurz, 2007), the
production of nitric oxide (NO) is significantly lower in
articular chondrocytes harboring mtDNA haplogroup J than in
non-J chondrocytes (Fernandez-Moreno et al., 2011). Based on
these findings, haplogroups J and H represent two different OA
phenotypes, leading to the consideration of these mtDNA
haplogroups as complementary genetic biomarkers of the
disease (Fernandez-Moreno et al., 2012).Frontiers in Genetics | www.frontiersin.org 4In terms of imaging biomarkers, the identification and
quantification of early bone marrow lesions (BMLs) has great
relevance for assessing symptomatic progression and
radiographic worsening over time in patients with OA
(Roemer et al., 2016). In this sense, a longitudinal study
including 255 participants from the OAI cohort that developed
incident knee OA at 48 months revealed that patients with
mtDNA haplogroup J were less likely to develop large BMLs in
the tibiofemoral compartment of the knee than those with
mtDNA haplogroup H (Rego-Perez et al., 2018). This
association could be due to the differential behavior of mtDNA
haplogroups H and J in terms of the metabolic activity and
inflammation that takes place in BMLs (Kuttapitiya et al., 2017).
In summary, in Caucasian populations, it seems that
haplogroups belonging to mitochondrial cluster JT are
protective against OA and have even been associated with
increased longevity in some European populations (Dato et al.,
2004). However, in energy-deficiency diseases, such as LHON
(Leber Hereditary Optic Neuropathy) these haplogroups,
specifically haplogroup J, are risk factors (Hudson et al., 2007).
This controversy is potentially related to the uncoupling nature
of the genetic polymorphisms associated with these haplogroups,
by which ATP production is reduced but, conversely, lower ROS
generation, oxidative damage, and apoptosis are also expected
(Ruiz-Pesini et al., 2004).THE MITOCHONDRIAL GENOME AS AN
EPIGENETIC REGULATOR IN ARTICULAR
CARTILAGE
It is well known that bi-directional communication exists
between the nucleus and mitochondria with the aim of
maintaining cellular homeostasis and regulating adaptation to
a broad range of stressors (Quirós et al., 2016; Wallace, 2016).
This communication implies, on the one hand, that
mitochondria are controlled by the nucleus by means of an
“anterograde regulation,” a mechanism that regulates
mitochondrial activity and biogenesis to provide cellular needs;
on the other hand, mitochondria and mtDNA variation maintain
partial regulatory signaling control over the nucleus through a
“retrograde regulation,” which leads to the modification of
cellular metabolism and function by activating the expression
of nuclear genes with the aim of protecting against mitochondrial
dysfunction (Jazwinski, 2013; Horan and Cooper, 2014;
Matilainen et al., 2017).
Based on the above findings, and taking into account the
reported associations between common mtDNA variants and
different physiological and pathological phenotypes (Gómez-
Durán et al., 2010; Martínez-Redondo et al., 2010; Marom
et al., 2017), it can be deduced that interactions between
mtDNA sequences, nuclear DNA, and the environment have
important effects on mammalian biology (Kenney et al., 2014). In
this sense, the effect of specific nuclear polymorphisms classically
identified as risk factors for different diseases, such as Parkinson´s
disease, cancer, and severe cardiopathy, is also modulated byJanuary 2020 | Volume 10 | Article 1335
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al., 2015). In the case of OA, as subjects carrying mtDNA
haplogroup J are not fully protected from suffering from the
disease, it would be interesting to investigate potential
interactions between this haplogroup, as well as the biochemically
opposite haplogroup H (Wallace et al., 1999; Martínez-Redondo et
al., 2010), and themost robust nuclear polymorphisms described in
different GWAS performed in OA (Warner and Valdes, 2017;
Zengini et al., 2018; Tachmazidou et al., 2019).
In terms of animal models, interesting work in conplastic
mice (mice with a constant nuclear background but different
mtDNA genomes) showed profound differences in health
longevity between conplastic strains. The level of divergence
between the two strains, equivalent to that between human
African and Eurasian mtDNAs, showed different behavior in
terms of mitochondrial proteostasis, reactive oxygen generation,
obesity, and insulin signaling as well as in cell-senescence-related
parameters such as telomere shortening and mitochondrial
dysfunction (Latorre-Pellicer et al., 2016). Most of the altered
processes described in the work of Latorre-Pellicer and co-
workers are also involved in many common human diseases.
In agreement with this, preliminary analyses of OA-related
features using the two strains of these animals revealed
significant differences between them in terms of the expression
of the autophagy-related protein microtubule-associated protein
1 light chain 3 (LC3) and extracellular matrix-degrading protein
metalloproteinase-13 (MMP-13) as well as significant differences
in the Mankin score, a scoring system for the histopathological
classification of the severity of cartilage lesions in OA (Scotece
et al., 2019).
In this context of mitochondrial-nuclear interactions,
epigenetics emerges as an important mechanism. Specifically,
DNA methylation is the best-characterized epigenetic
mechanism in OA. DNA methylation consists of the addition
of a methyl group (CH3) by S-adenosyl-methionine (SAM) to a
cytosine that lies at 5´ of guanine (CpG site) to give rise to
methylated cytosine. When this process occurs in high-density
CpG regions of promoters, gene silencing occurs; in contrast,
when methylation occurs in gene bodies, it leads to increased
gene expression (Hellman and Chess, 2007). In contrast to
nuclear DNA, the effects of mtDNA methylation in OA have
not been explored so far; however, it is well accepted that
mtDNA variation is able to modulate the nuclear methylome.
Consistent with this concept, two independent studies using
transmitochondrial cybrids showed that global DNA
methylation levels are differentially modulated by mtDNA
haplogroups J and H (Bellizzi et al., 2012; Atilano et al., 2015);
in addition, these two haplogroups also mediate the methylation
profile and the expression levels of genes involved in
angiogenesis, inflammation, and other signaling pathways
(Atilano et al., 2015). Moreover, different haplogroups on a
uniform nuclear background of mouse embryonic stem cells
were also associated with different methylation profiles and gene
expression (Kelly et al., 2013).
In the case of OA, DNA methylation is involved in the
phenotypic modulation that articular chondrocytes undergoFrontiers in Genetics | www.frontiersin.org 5during the OA process (Roach et al., 2005). After the few first
studies, in which the methylation pattern of specific genes
involved in OA pathogenesis was explored (Roach et al., 2005;
Hashimoto et al., 2013), genome-wide DNA methylation assays
were performed. These studies not only showed that knee and
hip OA cartilages have different DNA methylation patterns but
also identified a subgroup of OA patients with an enrichment of
altered genes involved in inflammation and immunity
(Fernandez-Tajes et al., 2014; Rushton et al., 2014). The only
study that has so far analyzed the effect of mtDNA variation on
the methylome of articular cartilage revealed that cartilages
harboring haplogroups H and J show a differential methylation
pattern, regardless of diagnosis. The study consisted of a
genome-wide DNA methylation approach followed by a whole
transcriptomic assay and demonstrated that apoptosis is
enhanced in haplogroup H cartilage samples, together with an
enrichment of overexpressed genes related to cell death; on the
contrary, apoptosis appeared more repressed in haplogroup J
cartilages. In addition, compared with H cartilages, samples with
haplogroup J also showed a significant enrichment of
hypomethylated CpGs of genes related to developmental
process, including those belonging to the homeobox family of
transcription factors, while H cartilages showed an enrichment
of genes related to metabolic processes (Cortes-Pereira et al.,
2019). These findings reflect that the epigenetic modifications
that occur during the pathogenesis of OA and affect different key
processes, such as metabolic alterations or apoptosis, vary
depending on the mitochondrial genetic background, and this
could determine the evolution of the disease (Figure 1).
Based on the description above, it is conceivable to consider the
mitochondrial genome as an epigenetic regulator of the nuclear
genome in articular cartilage. Stimuli such as reactive metabolic
intermediates from the mitochondrial metabolism, small RNAs,
mitochondria-derived peptides, and/or reactive oxygen species
could be considered among the underlying mechanisms by which
mitochondrial variation promotes modifications in the nuclear
DNA methylome in OA (Schroeder et al., 2013; Horan and
Cooper, 2014; Shadel and Horvath, 2015).CONCLUSIONS AND
FUTURE DIRECTIONS
The evidence presented in this review supports the hypothesis
that mitochondrial genetics not only influences different features
of OA disease but also modulates, in terms of mtDNA
haplogroups, the nuclear DNA methylome of the only cell type
present in articular cartilage, the chondrocyte. Based on this
evidence, a broad field of promising research lies ahead.
Efforts must be made in the use of conplastic mice to
investigate the influence of the mitochondrial background on
specific OA-related features in animal models that develop
spontaneous OA as well as in conplastic animals with induced
OA. On the other hand, of special interest would be the design of
transmitochondrial cybrids using chondrocytes as stable nuclear
donors to subsequently test the influence of mtDNA variants inJanuary 2020 | Volume 10 | Article 1335
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mediated by mitochondrial DNA haplogroups. As a consequence, different haplogroup-associated methylation patterns condition key processes related to the
development of OA. Permission is granted for publication of this figure as a modified version of the figure that appeared on page A17 of the July 2019 issue of
Arthritis & Rheumatology (Clinical Connections).Frontiers in Genetics | www.frontiersin.org January 2020 | Volume 10 | Article 13356
Rego-Pérez et al. Mitochondrial Variation in Osteoarthritisthe native cells of articular cartilage. The use of both animal and
cellular models, together with the methylation data originating
from different genome-wide methylation studies, could
contribute to the development of molecular biomarkers aimed
at identifying specific OA phenotypes from the design of CpG
class ifier panels combined with the mitochondria l
genetic background.
Given the role of adaptive selection in the origin of mtDNA
haplogroups, and recognizing that they could be maladaptive in
different environments with new lifestyles (Wallace, 2005), the
proposed study of potential interactions between mtDNA
variants and different nuclear DNA polymorphisms previously
associated with OA susceptibility in various GWAS should be
conducted taking into account the specific environment. Because
none of the studies described in Table 1 aimed to identify specific
or single mitochondrial polymorphisms associated with different
OA-related features, the precise identification through next-
generation sequencing techniques of these specific mtDNA
polymorphisms, characteristic or not of each haplogroup, from
both isolated blood and articular cartilage from the same patient,
would be a powerful tool for the consideration of mtDNA
variation as a potential robust biomarker of OA.
In terms of therapeutic research, the restoration of
mitochondrial function in OA chondrocytes would be the
ultimate goal. This can be achieved by using different
approaches to design different drugs that are capable of: i)
suppressing mitochondrial oxidative damage and restoring
extracellular matrix homeostasis (Farnaghi et al., 2017), ii)
activating the AMPK-SIRT1-PGC1a pathway to induce
mitochondrial biogenesis, therefore decreasing the pro-
catabolic response of chondrocytes (Wang et al., 2015), iii)
activating mitophagy, given its importance in preventing
mitochondrial dysfunction (López de Figueroa et al., 2015), or
iv) emulating the physiological effects of the OA-protective
mtDNA haplogroup J on mitochondrial activity, as well as
administering healthy isolated mitochondria into theFrontiers in Genetics | www.frontiersin.org 7osteoarthritic joint. On the other hand, given the bi-directional
communication between the nucleus and mitochondria,
interventions focused on the management of mitochondrial
dysfunction by targeting the epigenome, or vice versa
(Matilainen et al., 2017), would also be of interest.AUTHOR CONTRIBUTIONS
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